Biotech spinout from MIT's Langer Lab winds down operations
Lyndra Therapeutics, a drug developer that spun out of the lab of MIT professor Bob Langer in 2015, is winding down ...
Fernández Alcalde takes the reins at EMD Serono, one of Boston’s newest biotechs
Plus: JetBlue CEO eyes more growth in Boston; AG Andrea Campbell offers fiery words about Trump; Charles River chamber offers ...
STAT4d
Pfizer’s Wall Street critic-turned-executive digs into the company’s problems, obesity plans
Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...
This startup is using AI to give failed drugs a second chance. Check out the pitch deck it used to attract investors.
Ignota Labs is using AI to fix failed drugs and bring them to market. It raised $6.9 million from investors with this pitch ...